Ibrutinib in Japanese patients with relapsed/refractory B-cell malignancies: final analysis of phase I study

Kensei Tobinai; Toshiki Uchida; Noriko Fukuhara; Tomoaki Nishikawa

doi:10.1007/s12185-018-02577-8

Ibrutinib in Japanese patients with relapsed/refractory B-cell malignancies: final analysis of phase I study

Kensei Tobinai, Toshiki Uchida, Noriko Fukuhara, Tomoaki Nishikawa

Internal Medicine

Research output: Contribution to journal › Letter › peer-review

2 Citations (Scopus)

Original language	English
Pages (from-to)	366-368
Number of pages	3
Journal	International journal of hematology
Volume	109
Issue number	3
DOIs	https://doi.org/10.1007/s12185-018-02577-8
Publication status	Published - 2019 Mar 20

ASJC Scopus subject areas

Hematology

Access to Document

10.1007/s12185-018-02577-8

Cite this

@article{855d3df190b94a129c1c8705f9c2492e,

title = "Ibrutinib in Japanese patients with relapsed/refractory B-cell malignancies: final analysis of phase I study",

author = "Kensei Tobinai and Toshiki Uchida and Noriko Fukuhara and Tomoaki Nishikawa",

year = "2019",

month = mar,

day = "20",

doi = "10.1007/s12185-018-02577-8",

language = "English",

volume = "109",

pages = "366--368",

journal = "International Journal of Hematology",

issn = "0925-5710",

publisher = "Springer Japan",

number = "3",

}

TY - JOUR

T1 - Ibrutinib in Japanese patients with relapsed/refractory B-cell malignancies

T2 - final analysis of phase I study

AU - Tobinai, Kensei

AU - Uchida, Toshiki

AU - Fukuhara, Noriko

AU - Nishikawa, Tomoaki

PY - 2019/3/20

Y1 - 2019/3/20

UR - http://www.scopus.com/inward/record.url?scp=85059685366&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059685366&partnerID=8YFLogxK

U2 - 10.1007/s12185-018-02577-8

DO - 10.1007/s12185-018-02577-8

M3 - Letter

C2 - 30623356

AN - SCOPUS:85059685366

VL - 109

SP - 366

EP - 368

JO - International Journal of Hematology

JF - International Journal of Hematology

SN - 0925-5710

IS - 3

ER -